Research
New data reinforces XIIDRA's eye dryness relief among CL wearers
Open-label study evaluated effectiveness of lifitegrast 5%, noting significant improvements in end-of-day dryness and discomfort in just 2 weeks.
Products
Bausch + Lomb officially acquires Xiidra from Novartis
The $2.5 billion-deal also includes two “front-of-eye” assets.
Products